Primary Care Diabetes
Volume 4, Issue 2 , Pages 113-117 , July 2010

Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin

  • Kjeld Hermansen

      Affiliations

    • Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 89 49 76 51; fax: +45 89 49 76 59.
    • ,
  • Ronette L. Kolotkin

      Affiliations

    • Obesity and Quality of Life Consulting, PLLC, Durham, NC, USA
    • Department of Community and Family Medicine, Duke University Medical Center, Durham, NC USA
    • ,
  • Mette Hammer

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • Milan Zdravkovic

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • David Matthews

      Affiliations

    • Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
    • Oxford Biomedical Research Centre, NIHR, Oxford, UK

Received 18 January 2010 ,Accepted 7 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1751-9918(10)00048-3

doi: 10.1016/j.pcd.2010.04.001

Primary Care Diabetes
Volume 4, Issue 2 , Pages 113-117 , July 2010

Article Tools

* Image Usage & Resolution